
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $30 | $5.3M | $5.5M | $4.2M | $4.9M | |
Revenue Growth (YoY) | -- | 18434382.76% | 3.29% | -23.92% | 16.93% | |
Cost of Revenues | -- | $3.7M | $3.5M | $3.3M | $2.8M | |
Gross Profit | $30 | $1.7M | $2M | $895K | $2.1M | |
Gross Profit Margin | -- | 31.5% | 36.55% | 21.31% | 43.2% | |
R&D Expenses | -- | $504K | $697K | $418K | -- | |
Selling, General & Admin | $11.8K | $3M | $5.5M | $5.6M | $4.9M | |
Other Inc / (Exp) | $10K | -- | -- | -- | -$763K | |
Operating Expenses | $54.4K | $3.5M | $6.2M | $5.6M | $4.9M | |
Operating Income | -$54.3K | -$1.8M | -$4.2M | -$4.7M | -$2.8M | |
Net Interest Expenses | $1.9K | -- | $5K | $160K | $424K | |
EBT. Incl. Unusual Items | -$46.3K | -$1.8M | -$4.2M | -$4.8M | -$4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $5K | |
Net Income to Company | -$46.3K | -$1.8M | -$4.9M | -$6.9M | -$4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$46.3K | -$1.8M | -$4.2M | -$4.8M | -$4M | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.09 | -$0.04 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.09 | -$0.04 | -$0.02 | |
Weighted Average Basic Share | $133.7M | $161.7M | $54.3M | $177.6M | $183.9M | |
Weighted Average Diluted Share | $133.7M | $161.7M | $54.3M | $177.6M | $183.9M | |
EBITDA | -$1.7K | -$1.7M | -$3.7M | -$4.1M | -$2.9M | |
EBIT | -$44.3K | -$1.8M | -$4.2M | -$4.7M | -$3.5M | |
Revenue (Reported) | $30 | $5.3M | $5.5M | $4.2M | $4.9M | |
Operating Income (Reported) | -$54.3K | -$1.8M | -$4.2M | -$4.7M | -$2.8M | |
Operating Income (Adjusted) | -$44.3K | -$1.8M | -$4.2M | -$4.7M | -$3.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $1.1M | $876K | $1.2M | $1.6M | |
Revenue Growth (YoY) | -- | -- | -22.41% | 39.84% | 29.96% | |
Cost of Revenues | -- | $666K | $517K | $667K | $862K | |
Gross Profit | -- | $463K | $359K | $558K | $730K | |
Gross Profit Margin | -- | 41.01% | 40.98% | 45.55% | 45.85% | |
R&D Expenses | -- | $206K | $119K | -- | -- | |
Selling, General & Admin | $48K | $1.2M | $1.2M | $1.2M | $1.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $57.9K | $1.4M | $1.4M | $1.2M | $1.1M | |
Operating Income | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Net Interest Expenses | $3.2K | -- | $2K | $69K | $131K | |
EBT. Incl. Unusual Items | -$61.1K | -$933K | -$1M | -$735K | -$541K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$61.1K | -$933K | -$1.5M | -$1.2M | -$541K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$61.1K | -$933K | -$1M | -$735K | -$541K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -- | |
Weighted Average Basic Share | $143M | $161.7M | $172.7M | $183.9M | $184M | |
Weighted Average Diluted Share | $143M | $161.7M | $172.7M | $183.9M | $184M | |
EBITDA | -$48K | -$807K | -$859K | -$502K | -$264K | |
EBIT | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Revenue (Reported) | -- | $1.1M | $876K | $1.2M | $1.6M | |
Operating Income (Reported) | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Operating Income (Adjusted) | -$57.9K | -$933K | -$1M | -$666K | -$410K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $5.3M | $4.6M | $5.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $3.4M | $3.5M | $3M | |
Gross Profit | -- | $771K | $1.9M | $1.1M | $2.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $610K | $410K | -- | |
Selling, General & Admin | $57.2K | $2.9M | $5.6M | $5.5M | $4.9M | |
Other Inc / (Exp) | $10K | -- | -- | -- | -- | |
Operating Expenses | $109.7K | $3.3M | $6.2M | $5.4M | $4.8M | |
Operating Income | -$109.7K | -$2.5M | -$4.3M | -$4.3M | -$2.5M | |
Net Interest Expenses | -- | $1.9K | $7K | $227K | $486K | |
EBT. Incl. Unusual Items | -$85.3K | -$2.5M | -$4.3M | -$4.6M | -$3.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$2.7M | -$5.4M | -$6.6M | -$3.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$85.3K | -$2.5M | -$4.3M | -$4.6M | -$3.8M | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.04 | -$0.04 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.04 | -$0.04 | -$0.02 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$47.1K | -$2.3M | -$3.7M | -$3.7M | -$2.6M | |
EBIT | -$99.7K | -$2.5M | -$4.3M | -$4.3M | -$3.3M | |
Revenue (Reported) | -- | -- | $5.3M | $4.6M | $5.3M | |
Operating Income (Reported) | -$109.7K | -$2.5M | -$4.3M | -$4.3M | -$2.5M | |
Operating Income (Adjusted) | -$99.7K | -$2.5M | -$4.3M | -$4.3M | -$3.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $1.1M | $876K | $1.2M | $1.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $666K | $517K | $667K | $862K | |
Gross Profit | -- | $463K | $359K | $558K | $730K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $206K | $119K | -- | -- | |
Selling, General & Admin | $48K | $1.2M | $1.2M | $1.2M | $1.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $57.9K | $1.4M | $1.4M | $1.2M | $1.1M | |
Operating Income | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Net Interest Expenses | $3.2K | -- | $2K | $69K | $131K | |
EBT. Incl. Unusual Items | -$61.1K | -$933K | -$1M | -$735K | -$541K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$61.1K | -$933K | -$1.5M | -$1.2M | -$541K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$61.1K | -$933K | -$1M | -$735K | -$541K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -- | |
Weighted Average Basic Share | $143M | $161.7M | $172.7M | $183.9M | $184M | |
Weighted Average Diluted Share | $143M | $161.7M | $172.7M | $183.9M | $184M | |
EBITDA | -$48K | -$807K | -$859K | -$502K | -$264K | |
EBIT | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Revenue (Reported) | -- | $1.1M | $876K | $1.2M | $1.6M | |
Operating Income (Reported) | -$57.9K | -$933K | -$1M | -$666K | -$410K | |
Operating Income (Adjusted) | -$57.9K | -$933K | -$1M | -$666K | -$410K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $29K | $112K | $95K | $21K | $27K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $627K | $1M | $966K | $730K | |
Inventory | $10.9K | $1.2M | $2.6M | $1.3M | $890K | |
Prepaid Expenses | -- | $1.8M | $684K | $630K | $107K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $39.9K | $3.8M | $4.4M | $3M | $1.8M | |
Property Plant And Equipment | $2.3K | $355K | $2M | $1.5M | $721K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $290K | $270K | $270K | $270K | |
Total Assets | $49.3K | $4.4M | $6.7M | $4.7M | $2.7M | |
Accounts Payable | -- | $657K | $1.8M | $1.6M | $1.4M | |
Accrued Expenses | $9.1K | $260K | $681K | $1.1M | $1.1M | |
Current Portion Of Long-Term Debt | $92.8K | -- | $25K | $51K | $46K | |
Current Portion Of Capital Lease Obligations | -- | $73K | $561K | $619K | $581K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $101.9K | $1.2M | $3.7M | $8.4M | $8.3M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $101.9K | $1.4M | $30M | $34.1M | $33.5M | |
Common Stock | $133.7K | $25M | $173K | $184K | $184K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$52.6K | -$22M | -$23.4M | -$29.4M | -$30.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$52.6K | $3M | -$23.4M | -$29.4M | -$30.7M | |
Total Liabilities and Equity | $49.3K | $4.4M | $6.7M | $4.7M | $2.7M | |
Cash and Short Terms | $29K | $112K | $95K | $21K | $27K | |
Total Debt | $92.8K | -- | $25K | $51K | $46K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $3.9K | $21K | $103K | -- | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $716K | $718K | $935K | |
Inventory | -- | -- | $2.5M | $1.1M | $1.1M | |
Prepaid Expenses | -- | -- | $693K | $699K | $27K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $15.5K | $3.9M | $2.6M | $2M | |
Property Plant And Equipment | -- | -- | $1.9M | $1.3M | $575K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $270K | $270K | $250K | |
Total Assets | -- | $15.5K | $6.1M | $4.2M | $2.9M | |
Accounts Payable | -- | $7.6K | $1.1M | $1.1M | $1.6M | |
Accrued Expenses | -- | $8.3K | $1M | $1.1M | $1.1M | |
Current Portion Of Long-Term Debt | -- | $45K | -- | $51K | $71K | |
Current Portion Of Capital Lease Obligations | -- | -- | $578K | $608K | $494K | |
Other Current Liabilities | -- | -- | $16K | -- | -- | |
Total Current Liabilities | -- | $60.9K | $4.1M | $9.3M | $9M | |
Long-Term Debt | -- | $101.5K | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $162.4K | $5.3M | $34.9M | $34.1M | |
Common Stock | -- | $161.7K | $25.2M | $184K | $184K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -$146.9K | $831K | -$30.7M | -$31.3M | |
Total Liabilities and Equity | -- | $15.5K | $6.1M | $4.2M | $2.9M | |
Cash and Short Terms | -- | $3.9K | $21K | $103K | -- | |
Total Debt | -- | $146.5K | -- | $51K | $71K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$46.3K | -$1.8M | -$4.9M | -$6.9M | -$4M | |
Depreciation & Amoritzation | -- | $93K | $539K | $621K | $660K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | $245K | -$395K | $56K | $236K | |
Change in Inventories | -- | -$914K | -$1.3M | $403K | $179K | |
Cash From Operations | -$11.7K | -$4.3M | -$2.7M | -$3.3M | -$2.7M | |
Capital Expenditures | $800 | $18K | $263K | $42K | $42K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$850 | -$18K | -$263K | -$42K | -$42K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $250K | -- | |
Long-Term Debt Repaid | -$19.2K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $4.2M | $2.9M | $3.1M | $2.7M | |
Cash From Financing | -$19.2K | $4.2M | $2.9M | $3.3M | $2.7M | |
Beginning Cash (CF) | $60.8K | $258K | $112K | $95K | $21K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31.8K | -$146K | -$17K | -$74K | $6K | |
Ending Cash (CF) | $29K | $112K | $95K | $21K | $27K | |
Levered Free Cash Flow | -$12.6K | -$4.4M | -$2.9M | -$3.4M | -$2.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$61.1K | -$933K | -$1.5M | -$1.2M | -$541K | |
Depreciation & Amoritzation | $580 | $126K | $150K | $164K | $146K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | $225K | $306K | $248K | -$205K | |
Change in Inventories | -- | -$1.3M | $134K | $193K | -$183K | |
Cash From Operations | -$48K | -$694K | -$668K | -$804K | -$620K | |
Capital Expenditures | -- | $75K | $7K | $7K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$75K | -$7K | -$7K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $88K | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$47.2K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $950K | $601K | $893K | $590K | |
Cash From Financing | $40.8K | $950K | $601K | $893K | $593K | |
Beginning Cash (CF) | $29K | $112K | $95K | $21K | $27K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$7.2K | $181K | -$74K | $82K | -$27K | |
Ending Cash (CF) | $21.8K | $293K | $21K | $103K | -- | |
Levered Free Cash Flow | -$48K | -$769K | -$675K | -$811K | -$620K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$2.7M | -$5.4M | -$6.6M | -$3.3M | |
Depreciation & Amoritzation | -- | $218.4K | $563K | $635K | $642K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | $470K | -$314K | -$2K | -$217K | |
Change in Inventories | -- | -- | $106K | $462K | -$197K | |
Cash From Operations | -- | -$5M | -$2.6M | -$3.5M | -$2.5M | |
Capital Expenditures | -- | $75K | $195K | $42K | $35K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$195K | -$42K | -$35K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $2.6M | $3.4M | $2.4M | |
Cash From Financing | -- | $5.1M | $2.6M | $3.6M | $2.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $42.2K | -$272K | $82K | -$103K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$5M | -$2.8M | -$3.5M | -$2.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$61.1K | -$933K | -$1.5M | -$1.2M | -$541K | |
Depreciation & Amoritzation | $580 | $126K | $150K | $164K | $146K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | $225K | $306K | $248K | -$205K | |
Change in Inventories | -- | -$1.3M | $134K | $193K | -$183K | |
Cash From Operations | -$48K | -$694K | -$668K | -$804K | -$620K | |
Capital Expenditures | -- | $75K | $7K | $7K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$75K | -$7K | -$7K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $88K | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$47.2K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $950K | $601K | $893K | $590K | |
Cash From Financing | $40.8K | $950K | $601K | $893K | $593K | |
Beginning Cash (CF) | $29K | $112K | $95K | $21K | $27K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$7.2K | $181K | -$74K | $82K | -$27K | |
Ending Cash (CF) | $21.8K | $293K | $21K | $103K | -- | |
Levered Free Cash Flow | -$48K | -$769K | -$675K | -$811K | -$620K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.